Open AccessClinical values of two estrogen receptor signaling targeted lncRNAs in invasive ductal breast carcinoma
Author(s) -
S Ilbeigi,
Y Naeimzadeh,
Mosavar Farahani,
Mojdeh Monjezi,
Hassan Dastsooz,
Abdolreza Daraei,
Fereshteh Shahrabi Farahani,
A Dastgheib,
Yaser Mansoori,
S. Z. Tabei
Publication year - 2021
Publication title -
klinická onkologie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 13
eISSN - 1802-5307
pISSN - 0862-495X
DOI - 10.48095/ccko2021382
Subject(s) - downregulation and upregulation , cancer research , breast cancer , biology , ductal carcinoma , cancer , estrogen receptor , invasive ductal carcinoma , medicine , oncology , gene , genetics
Invasive ductal carcinoma (IDC) is the most frequent type of breast cancer (BC) in women, with a high clinical burden due to its high invasive properties. Despite of quickly emerging new data regarding the molecular heterogeneity of invasive cancers, far less is known about the molecular patterns among cases of IDC. An expanding body of evidence has demonstrated that dysregulation of long noncoding RNAs (lncRNAs) is involved in the heterogeneity feature of BC.